Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-9-17
pubmed:abstractText
Efficacy of a safe and clinically utilized polyethylene glycol formulation (PEG-3350) to suppress intestinal tumors was investigated in the Apc(min) mouse-model of experimental carcinogenesis. Furthermore, based on our previous finding on the induction of apoptosis in HT-29 cells by PEG, we evaluated its ability to stimulate epithelial cell apoptosis in both Apc(min) mouse as well as AOM-treated rat as a potential molecular mechanism of chemoprevention. Twenty-two Apc(min) mice were randomized equally to PEG or vehicle (control) supplementation. Tumors were scored and uninvolved intestinal mucosal apoptosis was assayed using a modified terminal deoxynucleotidyl transferase-mediated nick end-labeling (TUNEL) assay and by immunohistochemical detection of cleaved caspase-3. Supplementation of Apc(min) mice with 10% PEG 3350 (in drinking water) resulted in a 48% (P<0.05) reduction in intestinal tumor burden and induced 2-3 fold increase in mucosal apoptosis. Dietary supplementation of polyethylene glycol (5%) also stimulated colonic mucosal apoptosis 4-5 fold in AOM-treated rats, the regimen that we previously reported to reduce tumor burden by 76% (P<0.05). In summary, we demonstrate, for the first time, that PEG does protect against Apc(min) mouse tumorigenesis. The correlation between pro-apoptotic actions and chemopreventive efficacy of PEG in these models strongly implicates induction of apoptosis as one of the impending mechanisms of chemoprevention.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0304-3835
pubmed:author
pubmed:issnType
Print
pubmed:day
8
pubmed:volume
215
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
35-42
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15374630-Animals, pubmed-meshheading:15374630-Apoptosis, pubmed-meshheading:15374630-Azoxymethane, pubmed-meshheading:15374630-Carcinogens, pubmed-meshheading:15374630-Caspase 3, pubmed-meshheading:15374630-Caspases, pubmed-meshheading:15374630-Dietary Supplements, pubmed-meshheading:15374630-Epithelial Cells, pubmed-meshheading:15374630-Genes, APC, pubmed-meshheading:15374630-Humans, pubmed-meshheading:15374630-In Situ Nick-End Labeling, pubmed-meshheading:15374630-Intestinal Mucosa, pubmed-meshheading:15374630-Intestinal Neoplasms, pubmed-meshheading:15374630-Male, pubmed-meshheading:15374630-Mice, pubmed-meshheading:15374630-Mice, Knockout, pubmed-meshheading:15374630-Polyethylene Glycols, pubmed-meshheading:15374630-Rats, pubmed-meshheading:15374630-Rats, Inbred F344, pubmed-meshheading:15374630-Surface-Active Agents, pubmed-meshheading:15374630-Water
pubmed:year
2004
pubmed:articleTitle
Polyethylene glycol inhibits intestinal neoplasia and induces epithelial apoptosis in Apc(min) mice.
pubmed:affiliation
Department of Medicine, Evanston-Northwestern Healthcare Research Institute, 1001 University Place, Evanston, IL 60201, USA.
pubmed:publicationType
Journal Article, Comparative Study